Annals of Diagnostic Pathology
Volume 10, Issue 4 , Pages 215-221, August 2006

Nasopharyngeal adenocarcinomas: a clinicopathologic study of 44 cases including immunohistochemical features of 18 papillary phenotypes

  • Keyla Pineda-Daboin, MD

      Affiliations

    • Present address: Departamento de Patología, Military Hospital Carlos Arvelo, Caracas, Venezuela, and Instituto Anatomopatológico Jose A. Odely, Universidad Central de Venezuela, Caracas, Venezuela.
  • ,
  • Antonio Neto, MD

      Affiliations

    • Present address: Department of Pathology, Yale University School of Medicine, 20 York St., New Haven, CT 06504, USA.
  • ,
  • Valentina Ochoa-Perez, MD

      Affiliations

    • Present address: Departamento de Medicina, Military Hospital Carlos Arvelo, Caracas, Venezuela.
  • ,
  • Mario A. Luna, MD

      Affiliations

    • Corresponding Author InformationCorresponding author. Tel.: +1 713 792 3138; fax: +1 713 745 2247.

Department of Pathology, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA

Abstract 

Nasopharyngeal adenocarcinomas (NPACs) are uncommon neoplasms with a diverse histomorphology and clinical behavior. The purpose of our study was to better understand the clinicopathologic characteristics of NPACs and to identify the histologic and immunohistochemical features that distinguish the subtypes of papillary NPACs. We conducted a retrospective review of 44 cases of NPACs accessioned between 1985 and 2000. We obtained follow-up information for all patients. We identified 24 females and 20 males, ranging in age from 9 to 74 years (median, 50 years). There were 28 salivary gland type, 13 conventional low-grade papillary NPACs of surface origin, and 3 metastatic adenocarcinomas, 2 thyroid and 1 lung. We performed immunohistochemical studies in 18 papillary NPACs. Two of the low-grade papillary NPACs simulated thyroid carcinoma; they expressed CK7, CK19, and TTF-1 but were negative for thyroglobulin. Polymorphous low-grade papillary NPACs expressed diffuse reactivity to S-100, whereas low-grade papillary NPACs were negative or focally positive. All patients with low-grade NPACs were alive at 5 to 20 years. In contrast, 18 (64.2%) of the 28 patients with salivary gland–type NPACs had died of the disease or were living with disease at follow-up. Primary NPACs can be classified by their morphology and clinical behavior into 2 groups: surface origin type and salivary gland type. Papillary NPACs can be identified by their histology and selective immunohistochemical expression. Pathologist should distinguish the different types of NPACs because their treatment and prognosis differ.

Keywords: Nasopharynx, Adenocarcinoma, Papillary, Salivary gland, Immunohistochemistry

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1092-9134(05)00191-7

doi:10.1016/j.anndiagpath.2005.11.002

Annals of Diagnostic Pathology
Volume 10, Issue 4 , Pages 215-221, August 2006